HMGB1 and stroke disorder: By inhibiting HMGB1, GA may attenuate this EPC-driven angiogenesis, suggesting that GA’s therapeutic scope extends beyond inflammation control to modulation of neurovascular repair mechanisms, enriching its neuroprotective profile in stroke management.